Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded revision entry v3.5.0 and removed revision v3.4.3 from the page's revision history.SummaryDifference0.1%

- Check24 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No other content changes are indicated.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice that warned about potential delays in updates.SummaryDifference0.5%

- Check60 days agoChange DetectedAdded a site-wide funding/operational notice (including cc.nih.gov and opm.gov references) and updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check67 days agoChange DetectedAdded metadata fields such as Results First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted, a revision banner (v3.4.0), and a Show glossary toggle. These are UI/metadata updates and do not modify core study content.SummaryDifference0.4%

- Check81 days agoChange DetectedA minor version update from v3.3.3 to v3.3.4 was applied. No study details or user-facing content appear to be altered.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.